Previous Article | Next Article 
Molecular and Cellular Biology, December 2000, p. 9281-9293, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The MN1-TEL Fusion Protein, Encoded by the Translocation
(12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor
with Transforming Activity
Arjan
Buijs,1,*
Luc
van Rompaey,1
Anco C.
Molijn,2
J. Nathan
Davis,3
Alfred C. O.
Vertegaal,1
Mark D.
Potter,1
Constantin
Adams,1
Sjozèf
van Baal,1
Ellen C.
Zwarthoff,2
Martine F.
Roussel,3 and
Gerard
C.
Grosveld1,*
Department of Genetics1 and
Department of Tumor Cell Biology,3 St.
Jude Children's Research Hospital, Memphis, Tennessee 38105, and
Department of Pathology, Erasmus University, 3000 DR Rotterdam,
The Netherlands2
Received 1 September 2000/Accepted 20 September 2000
The Tel gene (or ETV6) is the target of the
translocation (12;22)(p13;q11) in myeloid leukemia. TEL is a member of
the ETS family of transcription factors and contains the pointed
protein interaction (PNT) domain and an ETS DNA binding domain (DBD). By contrast to other chimeric proteins that contain TEL's PNT domain,
such as TEL-platelet-derived growth factor
receptor in
t(5;12)(q33;p13), MN1-TEL contains the DBD of TEL. The N-terminal MN1
moiety is rich in proline residues and contains two polyglutamine stretches, suggesting that MN1-TEL may act as a deregulated
transcription factor. We now show that MN1-TEL type I, unlike TEL and
MN1, transforms NIH 3T3 cells. The transforming potential depends on
both N-terminal MN1 sequences and a functional TEL DBD. Furthermore, we
demonstrate that MN1 has transcription activity and that MN1-TEL acts
as a chimeric transcription factor on the Moloney sarcoma virus long terminal repeat and a synthetic promoter containing TEL binding sites.
The transactivating capacity of MN1-TEL depended on both the DBD of TEL
and sequences in MN1. MN1-TEL contributes to leukemogenesis by a
mechanism distinct from that of other chimeric proteins containing TEL.
*
Corresponding author. Present address for Arjan Buijs:
Department of Hematology, University Medical Center Utrecht,
Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Phone:
31-30-2507769. Fax: 31-30-2511893. E-mail:
a.buijs{at}lab.azu.nl. Mailing address for Gerard C. Grosveld: Department of Genetics, St. Jude Children's Research
Hospital, Memphis, TN 38105. Phone: (901) 495-2692. Fax: (901)
526-2907. E-mail: gerard.grosveld{at}stjude.org.
Molecular and Cellular Biology, December 2000, p. 9281-9293, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kandilci, A., Grosveld, G. C.
(2009). Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation. Blood
114: 1596-1606
[Abstract]
[Full Text]
-
Lambros, M B K, Tan, D S P, Jones, R L, Vatcheva, R, Savage, K, Tamber, N, Fenwick, K, Mackay, A, Ashworth, A, Reis-Filho, J S
(2009). Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication. J. Clin. Pathol.
62: 604-612
[Abstract]
[Full Text]
-
Liu, W., Lan, Y., Pauws, E., Meester-Smoor, M. A., Stanier, P., Zwarthoff, E. C., Jiang, R.
(2008). The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice. Development
135: 3959-3968
[Abstract]
[Full Text]
-
Meester-Smoor, M. A., Janssen, M. J.F.W., Grosveld, G. C., de Klein, A., van IJcken, W. F.J., Douben, H., Zwarthoff, E. C.
(2008). MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression. Carcinogenesis
29: 2025-2034
[Abstract]
[Full Text]
-
Heuser, M., Argiropoulos, B., Kuchenbauer, F., Yung, E., Piper, J., Fung, S., Schlenk, R. F., Dohner, K., Hinrichsen, T., Rudolph, C., Schambach, A., Baum, C., Schlegelberger, B., Dohner, H., Ganser, A., Humphries, R. K.
(2007). MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood
110: 1639-1647
[Abstract]
[Full Text]
-
Lierman, E., Cools, J.
(2007). ETV6 and PDGFRB: a license to fuse. haematol
92: 145-147
[Full Text]
-
Meester-Smoor, M. A, Molijn, A. C, Zhao, Y., Groen, N. A, Groffen, C. A H, Boogaard, M., van Dalsum-Verbiest, D., Grosveld, G. C, Zwarthoff, E. C
(2007). The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence. J Mol Endocrinol
38: 113-125
[Abstract]
[Full Text]
-
Heuser, M., Beutel, G., Krauter, J., Dohner, K., von Neuhoff, N., Schlegelberger, B., Ganser, A.
(2006). High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood
108: 3898-3905
[Abstract]
[Full Text]
-
Kawagoe, H., Grosveld, G. C.
(2005). Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9. Blood
106: 4269-4277
[Abstract]
[Full Text]
-
Kawagoe, H., Grosveld, G. C.
(2005). MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice. Blood
106: 4278-4286
[Abstract]
[Full Text]
-
Sutton, A. L. M., Zhang, X., Ellison, T. I., MacDonald, P. N.
(2005). The 1,25(OH)2D3-Regulated Transcription Factor MN1 Stimulates Vitamin D Receptor-Mediated Transcription and Inhibits Osteoblastic Cell Proliferation. Mol. Endocrinol.
19: 2234-2244
[Abstract]
[Full Text]
-
Nakamura, F., Nakamura, Y., Maki, K., Sato, Y., Mitani, K.
(2005). Cloning and Characterization of the Novel Chimeric Gene TEL/PTPRR in Acute Myelogenous Leukemia with inv(12)(p13q13). Cancer Res.
65: 6612-6621
[Abstract]
[Full Text]
-
Meester-Smoor, M. A., Vermeij, M., van Helmond, M. J. L., Molijn, A. C., van Wely, K. H. M., Hekman, A. C. P., Vermey-Keers, C., Riegman, P. H. J., Zwarthoff, E. C.
(2005). Targeted Disruption of the Mn1 Oncogene Results in Severe Defects in Development of Membranous Bones of the Cranial Skeleton. Mol. Cell. Biol.
25: 4229-4236
[Abstract]
[Full Text]
-
Kawagoe, H., Potter, M., Ellis, J., Grosveld, G. C.
(2004). TEL2, an ETS Factor Expressed in Human Leukemia, Regulates Monocytic Differentiation of U937 Cells and Blocks the Inhibitory Effect of TEL1 on Ras-Induced Cellular Transformation. Cancer Res.
64: 6091-6100
[Abstract]
[Full Text]
-
Maki, K., Arai, H., Waga, K., Sasaki, K., Nakamura, F., Imai, Y., Kurokawa, M., Hirai, H., Mitani, K.
(2004). Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation. Mol. Cell. Biol.
24: 3227-3237
[Abstract]
[Full Text]
-
Irvin, B. J., Wood, L. D., Wang, L., Fenrick, R., Sansam, C. G., Packham, G., Kinch, M., Yang, E., Hiebert, S. W.
(2003). TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL. J. Biol. Chem.
278: 46378-46386
[Abstract]
[Full Text]
-
Cools, J., Mentens, N., Odero, M. D., Peeters, P., Wlodarska, I., Delforge, M., Hagemeijer, A., Marynen, P.
(2002). Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood
99: 1776-1784
[Abstract]
[Full Text]
-
Yagasaki, F., Wakao, D., Yokoyama, Y., Uchida, Y., Murohashi, I., Kayano, H., Taniwaki, M., Matsuda, A., Bessho, M.
(2001). Fusion of ETV6 to Fibroblast Growth Factor Receptor 3 in Peripheral T-Cell Lymphoma with a t(4;12)(p16;p13) Chromosomal Translocation. Cancer Res.
61: 8371-8374
[Abstract]
[Full Text]
-
Cazzaniga, G., Daniotti, M., Tosi, S., Giudici, G., Aloisi, A., Pogliani, E., Kearney, L., Biondi, A.
(2001). The Paired Box Domain Gene PAX5 Is Fused to ETV6/TEL in an Acute Lymphoblastic Leukemia Case. Cancer Res.
61: 4666-4670
[Abstract]
[Full Text]